Takashi Kei Kishimoto - Net Worth and Insider Trading

Takashi Kei Kishimoto Net Worth

The estimated net worth of Takashi Kei Kishimoto is at least $124,597 dollars as of 2025-05-18. Takashi Kei Kishimoto is the Chief Scientific Officer of Cartesian Therapeutics Inc and owns about 12,144 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $124,597. Details can be seen in Takashi Kei Kishimoto's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Takashi Kei Kishimoto has not made any transactions after 2023-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Takashi Kei Kishimoto

To

Takashi Kei Kishimoto Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Takashi Kei Kishimoto owns 1 companies in total, including Cartesian Therapeutics Inc (RNAC) .

Click here to see the complete history of Takashi Kei Kishimoto’s form 4 insider trades.

Insider Ownership Summary of Takashi Kei Kishimoto

Ticker Company Transaction Date Type of Owner
RNAC Cartesian Therapeutics Inc 2023-01-05 Chief Scientific Officer

Takashi Kei Kishimoto Latest Holdings Summary

Takashi Kei Kishimoto currently owns a total of 1 stock. Takashi Kei Kishimoto owns 12,144 shares of Cartesian Therapeutics Inc (RNAC) as of January 5, 2023, with a value of $124,597.

Latest Holdings of Takashi Kei Kishimoto

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RNAC Cartesian Therapeutics Inc 2023-01-05 12,144 10.26 124,597

Holding Weightings of Takashi Kei Kishimoto


Takashi Kei Kishimoto Form 4 Trading Tracker

According to the SEC Form 4 filings, Takashi Kei Kishimoto has made a total of 3 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Cartesian Therapeutics Inc is the sale of 326 shares on January 5, 2023, which brought Takashi Kei Kishimoto around $11,056.

Insider Trading History of Takashi Kei Kishimoto

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Takashi Kei Kishimoto Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Takashi Kei Kishimoto Ownership Network

Ownership Network List of Takashi Kei Kishimoto

No Data

Ownership Network Relation of Takashi Kei Kishimoto

Insider Network Chart


Takashi Kei Kishimoto Owned Company Details

What does Cartesian Therapeutics Inc do?

Who are the key executives at Cartesian Therapeutics Inc?

Takashi Kei Kishimoto is the Chief Scientific Officer of Cartesian Therapeutics Inc. Other key executives at Cartesian Therapeutics Inc include Chief Financial Officer Blaine Davis , director & President & CEO Carsten Brunn , and Chief Medical Officer Peter G Traber .

Cartesian Therapeutics Inc (RNAC) Insider Trades Summary

Over the past 18 months, Takashi Kei Kishimoto made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 2,181,087 shares made by Timothy A Springer , a net sale of 1,797 shares made by , and a net sale of 17,271 shares made by Carsten Brunn .

In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 238,938 shares, with a net purchase of 238,938 shares. During the past 18 months, 278,198 shares of Cartesian Therapeutics Inc (RNAC) were sold and 1,006,048 shares were bought by its insiders, resulting in a net purchase of 727,850 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cartesian Therapeutics Inc Insider Transactions

No Available Data

Takashi Kei Kishimoto Mailing Address

Above is the net worth, insider trading, and ownership report for Takashi Kei Kishimoto. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Takashi Kei Kishimoto's mailing address is: Watertown Ma 02472.